Rebalix
Vanguard · sheet of 5 September 2026
Vanguard · sheet of 5 September 2026ETF sheet · official issuer and register data
Vanguard USD Corporate 1-3 Year Bond UCITS ETF EUR Hedged Acc
VCDE · IE00BGYWSW13 · EUR · domicile Ireland
Bonds · Corporate USD · 1-3 years · North AmericaEUR-hedged share classSFDR art. 6 (inferred)
Index tracked: Bloomberg Global Aggregate Corporate - United States Dollar Index
- TER
- 0.12%+ trans. 0.07%
- Fund size
- 3 bn EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 25.93%white list 0.55%
- Replication
- Physical (sampled)
- Income
- Accumulating
- Duration
- 1.90 yrsshort (≤3 years)
Launch 3 Oct 2023 · costs from the KID as of 2 Sept 2026 · 2,131 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the Bloomberg Global Aggregate Corporate – United States Dollar Index 1-3 Year (the “Index”). The Fund invests in a representative sample of bonds included in the Index in order to closely match the Index's capital and income return. The Index measures the performance of a broad spread of US dollar denominated bonds paying a fixed rate of interest which are issued by companies. Bonds in the Index…
Performance since series start (in euro) — base 100
30 Nov 2023 → 31 Jul 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +1.7% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +8.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 1.16% | 1.45% | — |
| Max drawdown | −0.98% | −0.98% | — |
| Sharpe | -0.80 | 0.21 | — |
| Sortino | -1.02 | 0.30 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VCDE · IE00BGYWSW131
RebalixVCDE · IE00BGYWSW13 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +3.58% | +3.75% | −0.17% |
| 2024 | +3.60% | +3.73% | −0.12% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.9%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 2,131 securities · top-10 weight = 4.3%
Countries (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
VCDE · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BGYWSW13
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BGYWSW13
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · VCDE · IE00BGYWSW132